AI-Derived CT Body Composition in Advanced Non-Small Cell Lung Cancer: A Multicohort Study
Tafadzwa L. Chaunzwa(Howard Hughes Medical Institute), Hugo J.W.L. Aerts(Harvard University), Jack M. Qian(South Shore Hospital), Biagio Ricciuti(Harvard University), J. Alessi(Dana-Farber Cancer Institute), Raymond H. Mak(Twitter (United States)), Alessandro Di Federico(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), M.M. Awad(Brigham and Women's Hospital), Eyal Jacob(AstraZeneca (United States)), D. Bikiel(AstraZeneca (United States)), Zhongyi Zhang(Intel (United States)), Quan Li(Nanchang University), J. Mackay(AstraZeneca (United States)), Ioannis Kagiampakis(Johns Hopkins University)
International Journal of Radiation Oncology*Biology*Physics
September 29, 2023
Cited by 1
Related Papers
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer
|JAMA Oncology|2020|498
Artificial intelligence in radiation oncology
|Nature Reviews Clinical Oncology|2020|399
Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
|JAMA Oncology|2022|383
Ambient Light Reduction Strategy to Synthesize Silver Nanoparticles and Silver-Coated TiO<sub>2</sub> with Enhanced Photocatalytic and Bactericidal Activities
|Langmuir|2003|292
Large language models to identify social determinants of health in electronic health records
|npj Digital Medicine|2024|275